# Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

> **NCT05441631** · PHASE1 · COMPLETED · sponsor: **Benha University** · enrollment: 436 (actual)

## Conditions studied

- COVID-19
- Dysglycemia

## Interventions

- **DRUG:** Insulin
- **DRUG:** Subcutaneous Insulin

## Key facts

- **NCT ID:** NCT05441631
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-07-15
- **Final completion:** 2021-12-01
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05441631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05441631, "Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05441631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*